Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in a Public School Population - a Population-based Observational Study to Inform Policy Making

NCT04448717 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT04448717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in a Public School Population - a Population-based Observational Study to Inform Policy Making
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Completed
Start date
June 16, 2020
Completion date
July 20, 2022
Enrollment
4,250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov 2